Porphyria clinical trials at UCSF
2 in progress, 1 open to eligible people
Porphyria is a rare disease related to heme production that can cause skin and nerve problems. UCSF is investigating porphyria through long-term studies to better understand its effects on health. Researchers are looking at aspects like the natural history of the disease and outcomes in pregnant patients.
Longitudinal Study of the Porphyrias
open to all eligible people
The objective of this protocol is to conduct a longitudinal multidisciplinary investigation of the human porphyrias including the natural history, morbidity, pregnancy outcomes, and mortality in people with these disorders.
San Francisco 5391959, California 5332921 and other locations
Long-Term Extension Study to Investigate the Safety, Tolerability, and Efficacy of DISC-1459 (Bitopertin) in Participants with EPP
Sorry, accepting new patients by invitation only
This is an open-label, long-term extension study to investigate the safety, tolerability and efficacy of DISC-1459 in participants with EPP.
San Francisco 5391959, California 5332921 and other locations
Our lead scientists for Porphyria research studies include Bruce Wang, MD.
Last updated: